The first shareholder derivative lawsuit hearing takes place today at Osaka District Court*Oasis seeks to hold directors accountable for the Beni-Koji incident and to help Kobayashi Pharma recover ...
Oticara’s intranasal steroid cream met co-primary endpoints, demonstrating significant improvements in 4CSS and SNOT-22Single ...
The recognition highlights Altior Healthcare's strong financial leadership and commitment to sustainable, patient-centered growth. LOS ANGELES, CA / ACCESS Newswire / October 13, 2025 / Altior ...
PLEASANTON, CA / ACCESS Newswire / October 13, 2025 / Healthcare Triangle Inc. (NASDAQ:HCTI) published a recent press release that included a headline that could've been mistaken for corporate filler- ...
GOTHENBURG, SWEDEN / ACCESS Newswire / October 13, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Invitation to attend XVIVO's conference call regarding the interim report July-September ...
Honoring the dedicated professionals who ensure safe, effective, and compassionate care for our community PALM SPRINGS, CA / ACCESS Newswire / October 13, 2025 / Desert Oasis Healthcare (DOHC) is ...
WASHINGTON, DC / ACCESS Newswire / October 13, 2025 / Healthcare providers are under unprecedented strain from rising claim denials, staffing shortages, and mounting margin pressures. To help meet ...
Alpha Nuclide's Research & Manufacturing Capabilities to Unlock Access to China Market, Targeting Clinical Trials for NY-703 ...
Countess of Chester Hospital NHS Foundation Trust Enhances Women’s Health Services with Ultrasound Upgrade ...
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United StatesEINDHOVEN, the Netherlands, Oct. 13, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V.
CHAPPER healthcare, AscellaHealth’s Global Pharmaceutical Distributor, Celebrates 50 Years of Global Pharmaceutical ExcellenceThis milestone marks half a century of innovation, reliability and access ...
Lundbeck’s bexicaserin receives Breakthrough Therapy Designation in China for the treatment of seizures in severe rare epilepsies·     Accelerated pathway underscores urgent need for innovative ...